share_log

BRIEF-ADC Therapeutics Reports Fourth Quarter And Year-End 2020 Results

路透社 ·  Mar 18, 2021 19:18
March 18 (Reuters) - ADC Therapeutics SA :
   * Q4 DILUTED LOSS PER SHARE 0.73 USD VERSUS 0.69 USD LOSS YEAR AGO
   * QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.73
   * QTRLY ADJUSTED NET LOSS PER SHARE, BASIC AND DILUTED $0.82

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment